Literature DB >> 22323582

Microchimerism in cord blood: mother as anticancer drug.

William J Burlingham1, J Lee Nelson.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22323582      PMCID： PMC3289348          DOI： 10.1073/pnas.1120857109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  11 in total

1.  Fetal microchimerism in breast from women with and without breast cancer.

Authors:  Vijayakrishna K Gadi
Journal:  Breast Cancer Res Treat       Date:  2009-09-19       Impact factor: 4.872

2.  Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs.

Authors:  Ewa Jankowska-Gan; Adam Sheka; Hans W Sollinger; John D Pirsch; R Michael Hofmann; Lynn D Haynes; Michael J Armbrust; Joshua D Mezrich; William J Burlingham
Journal:  Transplantation       Date:  2012-02-15       Impact factor: 4.939

3.  Acquisition of the rheumatoid arthritis HLA shared epitope through microchimerism.

Authors:  Zhen Yan; Tessa Aydelotte; V K Gadi; Katherine A Guthrie; J Lee Nelson
Journal:  Arthritis Rheum       Date:  2011-03

4.  Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

Authors:  Jon J van Rood; Fausto R Loberiza; Mei-Jie Zhang; Machteld Oudshoorn; Frans Claas; Mitchell S Cairo; Richard E Champlin; Robert Peter Gale; Olle Ringdén; Jill M Hows; Mary H Horowitz
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

5.  Fetal microchimerism persists at high levels in c-kit stem cells in sensitized mothers.

Authors:  Partha Dutta; Melanie L Dart; Steve M Schumacher; William J Burlingham
Journal:  Chimerism       Date:  2010-10

6.  Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization.

Authors:  J M Hall; P Lingenfelter; S L Adams; D Lasser; J A Hansen; M A Bean
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

7.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

8.  Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.

Authors:  Jeff E Mold; Jakob Michaëlsson; Trevor D Burt; Marcus O Muench; Karen P Beckerman; Michael P Busch; Tzong-Hae Lee; Douglas F Nixon; Joseph M McCune
Journal:  Science       Date:  2008-12-05       Impact factor: 47.728

9.  Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development.

Authors:  Anouk L Feitsma; Jane Worthington; Annette H M van der Helm-van Mil; Darren Plant; Wendy Thomson; Jennie Ursum; Dirkjan van Schaardenburg; Irene E van der Horst-Bruinsma; Jon J van Rood; Tom W J Huizinga; René E M Toes; René R P de Vries
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

10.  Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor.

Authors:  Martin Stern; Loredana Ruggeri; Antonella Mancusi; Maria Ester Bernardo; Claudia de Angelis; Christoph Bucher; Franco Locatelli; Franco Aversa; Andrea Velardi
Journal:  Blood       Date:  2008-05-20       Impact factor: 22.113
View more
  8 in total

1.  Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.

Authors:  Colin de Haar; Maud Plantinga; Nina Jg Blokland; Niek P van Til; Thijs Wh Flinsenberg; Viggo F Van Tendeloo; Evelien L Smits; Louis Boon; Lotte Spel; Marianne Boes; Jaap Jan Boelens; Stefan Nierkens
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

Review 2.  Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.

Authors:  Michael Eikmans; Astrid G S van Halteren; Koen van Besien; Jon J van Rood; Jos J M Drabbels; Frans H J Claas
Journal:  Chimerism       Date:  2014

3.  Microchimerism and allogeneic transplantation: we need the proof in the pudding.

Authors:  Koen van Besien; Hong-Tao Liu; Andrew Artz
Journal:  Chimerism       Date:  2013-03-19

Review 4.  Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.

Authors:  Koen Van Besien; Hongtao Liu; Nitin Jain; Wendy Stock; Andrew Artz
Journal:  Biol Blood Marrow Transplant       Date:  2012-11-08       Impact factor: 5.742

Review 5.  Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.

Authors:  Coco de Koning; Rick Admiraal; Stefan Nierkens; Jaap Jan Boelens
Journal:  Stem Cell Investig       Date:  2017-05-16

6.  Factors Predicting the Presence of Maternal Cells in Cord Blood and Associated Changes in Immune Cell Composition.

Authors:  Marina El Haddad; Karlin R Karlmark; Xavier-Côme Donato; Gabriel V Martin; Florence Bretelle; Nathalie Lesavre; Jean-François Cocallemen; Marielle Martin; Christophe Picard; Jean Roudier; Raoul Desbriere; Nathalie C Lambert
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

7.  Mother and child T cell receptor repertoires: deep profiling study.

Authors:  Ekaterina V Putintseva; Olga V Britanova; Dmitriy B Staroverov; Ekaterina M Merzlyak; Maria A Turchaninova; Mikhail Shugay; Dmitriy A Bolotin; Mikhail V Pogorelyy; Ilgar Z Mamedov; Vlasta Bobrynina; Mikhail Maschan; Yuri B Lebedev; Dmitriy M Chudakov
Journal:  Front Immunol       Date:  2013-12-25       Impact factor: 7.561

Review 8.  Is the Benefit-Risk Ratio for Patients with Transfusion-Dependent Thalassemia Treated by Unrelated Cord Blood Transplantation Favorable?

Authors:  Tang-Her Jaing
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.